产品封面图
文献支持

支气管上皮细胞培养基

收藏
  • ¥1600
  • Sciencell
  • B-3211
  • 美国
  • 2025年08月01日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 库存

      100

    • 供应商

      上海酶研生物科技有限公司

    • 英文名

      BEpiCM (Bronchial Epithelial Cell Medium)

    • 规格

      500ml/T

    货号

    3211

    产地

    美国

    缩写

    BEpiCM

    规格

    500ml

    用途

    科研

    储存

    4度,-20度

    运输

    胶冰

    支气管上皮细胞培养基是为正常人类支气管上皮细胞体外培养设计的适于其生长的培养基。无血清培养基是无菌的、液体培养基,包含必需和非必需氨基、维生素、有机和无机化合物、激素、生长因子、微量矿物质。该培养基不含血清。该培养基含碳酸氢盐缓冲体系,在5%二氧化碳/95%空气培养箱中平衡时PH值为7.4。该培养基在数量上和质量上都保证理想的营养平衡状态,选择性促进体外正常人类支气管上皮细胞的生长。
    成分
      支气管上皮细胞培养基包含500 ml基础培养基,5 ml支气管上皮细胞生长添加物,(BEpiCGS,目录编号3262)和5 ml青霉素/链霉素溶液(P/S,目录编号0503)

    1. Bai, X.Y., Zhang, X.C., Yang, S.Q., An, S.J., Chen, Z.H., Su, J., Xie, Z., Gou, L.Y. & Wu, Y.L. (2016) Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines PLoS One. 11

    Aberrant activation of the hedgehog (Hh) signaling pathway has been implicated in the epithelial-to-mesenchymal transition (EMT) and cancer stem-like cell (CSC) maintenance; both processes can result in tumor progression and treatment resistance in several types of human cancer. Hh cooperates with the epidermal growth factor receptor (EGFR) signaling pathway in embryogenesis. We found that the Hh signaling pathway was silenced in EGFRTKI-sensitive non-small-cell lung cancer (NSCLC) cells, while it was inappropriately activated in EGFR-TKI-resistant NSCLC cells, accompanied by EMT induction and ABCG2 overexpression. Upregulation of Hh signaling through extrinsic SHH exposure downregulated E-cadherin expression and elevated Snail and ABCG2 expression, resulting in gefitinib tolerance (P < 0.001) in EGFR-TKI-sensitive cells. Blockade of the Hh signaling pathway using the SMO antagonist SANT-1 restored E-cadherin expression and downregulate Snail and ABCG2 in EGFR-TKI-resistant cells. A combination of SANT-1 and gefitinib markedly inhibited tumorigenesis and proliferation in EGFR-TKI-resistant cells (P < 0.001). These findings indicate that hyperactivity of Hh signaling resulted in EGFR-TKI resistance, by EMT introduction and ABCG2 upregulation, and blockade of Hh signaling synergistically increased sensitivity to EGFR-TKIs in primary and secondary resistant NSCLC cells. E-cadherin expression may be a potential biomarker of the suitability of the combined application of an Hh inhibitor and EGFR-TKIs in EGFR-TKI-resistant NSCLCs. Less

    2. Crowley, C., Klanrit, P., Butler, C.R., Varanou, A., Plat, M., Hynds, R.E., Chambers, R.C., Seifalian, A.M., Birchall, M.A. & Janes, S.M. (2016) Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold Biomaterials. 83

    Polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) is a versatile nanocomposite biomaterial with growing applications as a bioscaffold for tissue engineering. Integration of synthetic implants with host tissue can be problematic but could be improved by topographical modifications. We describe optimization of POSS-PCU by dispersion of porogens (sodium bicarbonate (NaHCO3), sodium chloride (NaCl) and sucrose) onto the material surface, with the principle aim of increasing surface porosity, thus providing additional opportunities for improved cellular and vascular ingrowth. We assess the effect of the porogens on the material's mechanical strength, surface chemistry, wettability and cytocompatibilty. Surface porosity was characterized by scanning electron microscopy (SEM). There was no alteration in surface chemistry and wettability and only modest changes in mechanical properties were detected. The size of porogens correlated well with the porosity of the construct produced and larger porogens improved interconnectivity of spaces within constructs. Using primary human bronchial epithelial cells (HBECs) we demonstrate moderate in vitro cytocompatibility for all surface modifications; however, larger pores resulted in cellular aggregation. These cells were able to differentiate on POSS-PCU scaffolds. Implantation of the scaffold in vivo demonstrated that larger pore sizes favor cellular integration and vascular ingrowth. These experiments demonstrate that surface modification with large porogens can improve POSS-PCU nanocomposite scaffold integration and suggest the need to strike a balance between the non-porous surfaces required for epithelial coverage and the porous structure required for integration and vascularization of synthetic scaffolds in future construct design. Keywords: Biocompatible materials; Nanocomposites; Porosity; Re-epithelialization; Tissue engineering; Trachea. Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved. Less

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

     

    1.) Kokubun K, Pankajakshan D, Kim MJ, Agrawal DK. (2013) "Differentiation of porcine mesenchymal stem cells into epithelial cells as a potential therapeutic application to facilitate epithelial regeneration." J Tissue Eng Regen Med. doi: 10.1002/term.1758.

    相关实验
    • 正常人支气管上皮细胞培养

      实验材料: 1. 手术切除的含支气管的正常肺组织 2. 胰蛋白酶/EDTA液:0.05%胰蛋白酶,0.5mmol/L EDTA 3. 6孔培养板:用多聚赖氨酸包被 4. 不含Ca2+ 和Mg2+的1×PBS(pH=7.2),添加200000IU/L青霉素、200mg/L链霉素和200000U/L庆大霉素,pH7.4 5. 手术刀、解剖剪、解剖镊、眼科剪,眼科镊 6. 离心管(15ml、50ml) 实验方法: 1. 将分离的两片肺叶组织用含双抗的1×PBS

    • 动物气管和支气管假复层纤毛柱状上皮细胞的培养

      冲洗,以除去血液和粘液。 2. 将气管或支气管的一端结扎,另一端插套管并固定。用注射器经套管注入1%中性蛋白酶,至气管充盈为止。将气管浸泡于PBS中,在37℃条件下消化20min。 3. 用注射器抽取培养液,将注射器插入套管,反复冲洗,以分离气管上皮细胞。然后,将气管或支气管游离端的结扎线剪断,回收管腔内的细胞悬液。 4. 用200目不锈钢网筛过滤,将滤液离心(1000r/min,10min)。弃上清液后,再用培养液洗涤离心1次。 5. 用培养液悬浮沉淀细胞,调整细胞

    • 肺泡alveoli

      哺乳类肺的构造是一种复囊状腺,气管是由主支气管→叶支气管支气管支,反复分枝,其末端终于肺的呼吸部,即实际上进行气体交换的部位。呼吸部的壁形成多数半球状膨出,各膨出部称为肺泡。肺泡的内壁由固有的单层扁平上皮所覆盖,介基底膜与毛细血管的单层扁平上皮相接,两种上皮细胞都具有多数细胞间隙,这是符合两种上皮细胞进行气体交换的需要,构造与机能相一致。由于肺泡的形成,呼吸面积极度增大,成人的表面积总合接近100平方米。  

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    上海和序生物科技有限公司
    2026年01月04日询价
    ¥2352
    亿泽丰生物科技(上海)有限公司
    2026年01月09日询价
    询价
    上海柯雷生物科技有限公司
    2025年07月06日询价
    ¥1600
    博辉生物科技(广州)有限公司
    2025年08月01日询价
    ¥1600
    上海酶研生物科技有限公司
    2025年08月01日询价
    文献支持
    支气管上皮细胞培养基
    ¥1600